Novavax, Inc. (NVAX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Novavax, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 2.47x | -6.53x | -0.89x | -1.22x | -6.10x | -15.34x |
| P/B Ratio | -8.52x | -1.96x | -0.67x | -1.27x | -30.27x | 10.23x |
| P/S Ratio | 0.97x | 1.79x | 0.87x | 0.50x | 53.87x | 286.66x |
| Profitability | ||||||
| Gross Margin | 93.7% | 70.3% | 38.2% | 43.5% | 100.0% | 100.0% |
| Operating Margin | 50.1% | -36.5% | -101.8% | -40.3% | -853.6% | -1861.3% |
| Net Margin | 39.2% | -27.5% | -98.0% | -41.1% | -882.5% | -1868.2% |
| EBITDA Margin | 43.8% | -15.8% | -87.6% | -37.8% | -850.7% | -1778.8% |
| Liquidity | ||||||
| Current Ratio | 2.13x | 0.98x | 0.70x | 0.69x | 0.90x | 2.15x |
| Quick Ratio | 2.10x | 0.97x | 0.67x | 0.68x | 0.90x | 2.15x |
| Leverage | ||||||
| Debt/Equity | -1.95x | -0.37x | -0.32x | -0.87x | -1.29x | 0.75x |
YoY = year-over-year change. Source: FMP..